What is Loncastuximab Tesirine: Uses, Dosage, Side Effects and More

Loncastuximab tesirine is a targeted cancer medication designed to treat certain types of blood cancers, specifically large B-cell lymphoma. This medication works like a guided missile, delivering chemotherapy directly to cancer cells while trying to spare healthy tissue. It's typically reserved for patients whose cancer has returned or hasn't responded to other treatments, offering hope when other options have been exhausted.

What is Loncastuximab Tesirine?

Loncastuximab tesirine is an antibody-drug conjugate, which means it combines a targeted antibody with a powerful chemotherapy drug. Think of it as a smart delivery system that seeks out specific cancer cells and delivers treatment directly to them. The medication specifically targets CD19, a protein found on the surface of certain blood cancer cells.

This medication belongs to a newer class of cancer treatments that aim to be more precise than traditional chemotherapy. Instead of affecting all rapidly dividing cells in your body, it focuses its attack on cancer cells that display the CD19 protein. This targeted approach can help reduce some of the side effects you might experience with conventional chemotherapy.

The drug is administered intravenously, meaning it's given through a vein in your arm over a specific period. Your healthcare team will carefully monitor you during and after each infusion to ensure you're responding well to the treatment.

What is Loncastuximab Tesirine Used For?

Loncastuximab tesirine is specifically approved to treat relapsed or refractory large B-cell lymphoma. This means it's used when your lymphoma has either come back after previous treatment or hasn't responded adequately to at least two prior therapies. Your oncologist will typically consider this medication when other standard treatments haven't been successful.

Large B-cell lymphoma is a type of non-Hodgkin lymphoma that affects your lymphatic system, which is part of your body's infection-fighting network. When this cancer is described as "relapsed," it means it returned after a period of remission. "Refractory" means the cancer didn't respond well to previous treatments or continued to grow despite therapy.

Your doctor will need to confirm that your cancer cells express the CD19 protein before recommending this treatment. This is done through laboratory testing of your cancer tissue. Not all lymphomas will be suitable for this medication, which is why proper testing is essential before starting treatment.

How Does Loncastuximab Tesirine Work?

Loncastuximab tesirine works as a powerful, targeted cancer treatment that combines precision with strength. The medication consists of two main parts: an antibody that acts like a GPS system to find cancer cells, and a potent chemotherapy drug that destroys them once delivered. This makes it a strong medication reserved for serious situations when other treatments haven't worked.

Here's how the process unfolds in your body. First, the antibody portion seeks out and binds to CD19 proteins on the surface of your cancer cells. Once attached, the entire medication gets absorbed into the cancer cell. Inside the cell, the chemotherapy component is released and begins destroying the cancer from within.

This targeted approach means the medication can deliver a concentrated dose of chemotherapy directly to cancer cells while minimizing exposure to healthy tissues. However, because the chemotherapy component is quite potent, you may still experience side effects as some healthy cells can also be affected during the process.

How Should I Take Loncastuximab Tesirine?

Loncastuximab tesirine is always given as an intravenous infusion in a healthcare setting, never as a pill you take at home. Your treatment team will administer it slowly through a vein in your arm over approximately 30 minutes. The medication comes in cycles, typically given every three weeks, allowing your body time to recover between treatments.

Before each infusion, you'll likely receive pre-medications to help prevent allergic reactions and reduce the risk of side effects. These might include antihistamines, steroids, or fever reducers. Your healthcare team will monitor your vital signs closely during the infusion and for a period afterward to watch for any immediate reactions.

You don't need to take this medication with food since it's given intravenously. However, it's important to stay well-hydrated on treatment days and follow any specific instructions your healthcare team provides. Some patients find it helpful to eat a light meal before coming in for treatment to help prevent nausea.

Plan to spend several hours at the treatment center for each session. This includes time for pre-medications, the actual infusion, and post-treatment monitoring. Bringing a book, tablet, or having someone accompany you can help make the time more comfortable.

How Long Should I Take Loncastuximab Tesirine For?

The duration of loncastuximab tesirine treatment depends on how well your cancer responds and how your body tolerates the medication. Most patients receive the treatment for several cycles, with each cycle spaced three weeks apart. Your oncologist will regularly assess your progress through blood tests and imaging studies to determine if you should continue treatment.

Treatment typically continues as long as your cancer is responding and you're not experiencing severe side effects. Some patients may complete their planned course of treatment, while others might need to stop early if side effects become too difficult to manage. Your healthcare team will work closely with you to find the right balance between fighting your cancer and maintaining your quality of life.

Regular monitoring appointments are crucial during treatment. These visits allow your doctor to check how well the medication is working and adjust your treatment plan if needed. Blood tests will monitor your blood cell counts, liver function, and other important markers of your body's response to treatment.

What Are the Side Effects of Loncastuximab Tesirine?

Loncastuximab tesirine can cause a range of side effects, from mild to serious, as your body responds to this powerful cancer treatment. Understanding what to expect can help you prepare and know when to contact your healthcare team. Remember that not everyone experiences all side effects, and your medical team will work with you to manage any that occur.

The most common side effects you might experience include fatigue, nausea, and low blood cell counts. These effects occur because the medication affects both cancer cells and some healthy cells in your body. Many patients find these symptoms manageable with proper support and medications.

Here are the more frequent side effects that patients commonly report:

• Fatigue and weakness that may persist between treatments
• Nausea and vomiting, especially in the first few days after infusion
• Low white blood cell counts, increasing infection risk
• Low platelet counts, leading to easy bruising or bleeding
• Decreased appetite and potential weight loss
• Skin rash or itching at various sites
• Diarrhea or changes in bowel habits
• Muscle or joint aches

These common side effects are generally manageable with supportive care and medications that your healthcare team can prescribe.

Some patients may experience more serious side effects that require immediate medical attention. These rare but important complications include severe infections due to low white blood cell counts, significant bleeding problems from low platelet counts, or serious liver problems. Additionally, some patients may develop a severe skin reaction called Stevens-Johnson syndrome, which appears as painful blistering of the skin and mucous membranes.

Here are the serious side effects that require prompt medical care:

• Signs of serious infection like fever, chills, or persistent cough
• Unusual bleeding or bruising that doesn't stop easily
• Severe skin reactions with blistering or peeling
• Yellowing of skin or eyes suggesting liver problems
• Severe fatigue that interferes with daily activities
• Difficulty breathing or chest pain
• Severe nausea preventing you from keeping fluids down

Your healthcare team will monitor you carefully for these effects and provide immediate treatment if they occur. Don't hesitate to contact them if you notice any concerning symptoms between appointments.

Who Should Not Take Loncastuximab Tesirine?

Loncastuximab tesirine isn't suitable for everyone, and your oncologist will carefully evaluate whether it's the right choice for your specific situation. Certain health conditions or circumstances may make this medication too risky or less effective for some patients. Your medical team will review your complete health history before recommending this treatment.

Patients with severe liver disease may not be good candidates for this medication since it can affect liver function. Similarly, those with active, serious infections should typically wait until the infection is controlled before starting treatment. Your doctor will also consider your overall health status and ability to tolerate the treatment's demands.

Pregnancy and breastfeeding are important considerations with this medication. Loncastuximab tesirine can harm a developing baby, so women of childbearing age will need to use effective contraception during treatment and for several months afterward. If you're breastfeeding, you'll need to stop before beginning treatment.

Here are specific situations where this medication may not be appropriate:

• Severe liver disease or significantly abnormal liver function tests
• Active, uncontrolled serious infections
• Pregnancy or plans to become pregnant
• Breastfeeding mothers
• Severely compromised immune system from other causes
• Recent live vaccines (should be avoided during treatment)
• Severe heart problems that make infusion risky

Your oncologist will weigh these factors against the potential benefits of treatment to make the best recommendation for your situation.

Loncastuximab Tesirine Brand Name

Loncastuximab tesirine is marketed under the brand name Zynlonta in the United States. This brand name is what you'll typically see on medication labels and in discussions with your healthcare team. The medication was developed by ADC Therapeutics and received FDA approval for treating relapsed or refractory large B-cell lymphoma.

When discussing your treatment with insurance companies or pharmacies, both the generic name (loncastuximab tesirine) and brand name (Zynlonta) may be used. Your healthcare team will help coordinate with your insurance to ensure coverage and address any questions about the medication's availability or cost.

Loncastuximab Tesirine Alternatives

Several other treatment options exist for relapsed or refractory large B-cell lymphoma, though the best choice depends on your specific situation, previous treatments, and overall health. Your oncologist will consider factors like your cancer's characteristics, your response to prior therapies, and your ability to tolerate different treatments when discussing alternatives.

CAR-T cell therapy represents one of the most promising alternatives for patients with relapsed large B-cell lymphoma. This treatment involves removing your own immune cells, genetically modifying them to better fight cancer, and then reinfusing them back into your body. While potentially very effective, CAR-T cell therapy requires specialized centers and can cause unique side effects.

Other antibody-drug conjugates like polatuzumab vedotin may be options depending on your cancer's specific markers. Traditional chemotherapy combinations, clinical trials with experimental treatments, or stem cell transplantation might also be considered based on your individual circumstances.

Here are some alternative treatments your oncologist might discuss:

• CAR-T cell therapy (tisagenlecleucel or axicabtagene ciloleucel)
• Polatuzumab vedotin combined with chemotherapy
• Clinical trials with newer investigational drugs
• Autologous or allogeneic stem cell transplantation
• Combination chemotherapy regimens like R-ICE or R-DHAP
• Radiation therapy for localized disease

Your healthcare team will help you understand the pros and cons of each option and guide you toward the most appropriate treatment for your specific situation.

Is Loncastuximab Tesirine Better Than Rituximab?

Loncastuximab tesirine and rituximab work differently and are typically used at different stages of lymphoma treatment, making direct comparisons challenging. Rituximab is usually part of first-line treatment combinations, while loncastuximab tesirine is reserved for cancers that have relapsed or haven't responded to multiple prior therapies including rituximab.

Rituximab is a monoclonal antibody that targets CD20 on B-cells and has been a cornerstone of lymphoma treatment for many years. It's generally well-tolerated and often combined with chemotherapy in regimens like R-CHOP. Loncastuximab tesirine, being an antibody-drug conjugate targeting CD19, delivers chemotherapy directly to cancer cells but tends to have more significant side effects.

In the context of relapsed or refractory disease, loncastuximab tesirine may offer benefits that rituximab-based treatments cannot provide. However, your oncologist will consider your complete treatment history, current health status, and cancer characteristics to determine the most appropriate approach for your specific situation.